ELI LILLY & CO (LLY)
Clinical trial NCT06721013 updates: 1. completion date: 2027-02-01 → 2029-05-01 2. primary completion date: 2026-12-01 → 2028-05-01 3. enrollment: 58 → 68 participants
Clinical trial NCT06721013 updates: 1. completion date: 2027-02-01 → 2029-05-01 2. primary completion date: 2026-12-01 → 2028-05-01 3. enrollment: 58 → 68 participants
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical